Interactions between N-methyl-D-aspartate receptor antagonists and the discriminative stimulus effects of morphine in rats

Pharmacology Biochemistry and Behavior

Volumn 60, Issue 2, 1998, Pages 507-517

  Bespalov, Anton Y ^a   Beardsley, Patrick M ^a   Balster, Robert L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dizocilpine; Drug discrimination; Eliprodil; HA 966 Kynurenic acid; Morphine; NMDA antagonists; NPC17742; SDZ220 581

Indexed keywords

2 AMINO 4,5 (1,2 CYCLOHEXYL) 7 PHOSPHONOHEPTANOIC ACID; 3 AMINO 1 HYDROXY 2 PYRROLIDINONE; DIZOCILPINE; ELIPRODIL; KYNURENIC ACID; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALTREXONE; SDZ 220581; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG DISCRIMINATION; FOOD; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BINDING, COMPETITIVE; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; GENERALIZATION, STIMULUS; MALE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RATS; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032101135     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00006-9     Document Type: Article

References (71)

1. Advokat C., Rhein F.Q. Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA antagonist dextrorphan. Brain Res. 699:1995;157-160.
2. Balster R.L., Nicholson K.L., Sanger D.J. Evaluation of the reinforcing effects of eliprodil in rhesus monkeys and its discriminative stimulus effects in rats. Drug Alcohol Depend. 35:1994;211-216.
3. Balster R.L., Mansbach R.S., Shelton K.L., Nicholson K.L., Grech D.M., Wiley J.L., Li H., Weber E. Behavioral pharmacology of two novel substituted quinoxalinedione glutamate antagonists. Behav. Pharmacol. 6:1995;577-589.
4. Balster R.L., Willetts J. Phencyclidine. A drug of abuse and a tool for neuroscience research Schuster C.R., Kuhar M.J. Pharmacological aspects of drug dependence. Towards an integrated neurobehavioral approach:1996;233-262 Springer Verlag, Handbook of experimental pharmacology, vol. 118. Berlin.
5. Bernardi M., Bertolini A., Szczawinska K., Genedani S. Blockade of the polyamine site of NMDA receptors produces antinociception and enhances the effect of morphine, in mice. Eur. J. Pharmacol. 298:1996;51-55.
6. Bespalov A.Y., Dumpis M.A., Piotrovsky L.B., Zvartau E.E. Excitatory amino acid receptors antagonist kynurenic acid attenuates rewarding potential of morphine. Eur. J. Pharmacol. 264:1994;233-239.
7. Bespalov, A. Y.; Zvartau, E. E.: Influence of kynurenic acid on the acquisition of intravenous morphine self-administration in rats. Bull. Exp. Biol. Med.; (in press).
8. Bobelis D.J., Balster R.L. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid (Npc 12626), a competitive N-methyl-D-aspartate receptor antagonist. J. Pharmacol. Exp. Ther. 264:1993;845-853.
9. Browne R.G., Weissman A. Discriminative stimulus properties of delta-9-tetrahydrocannabinol. Mechanistic studies J. Clin. Pharmacol. 21:1981;227S-234S.
10. Carlezon W.A. Jr., Wise R.A. Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801. Brain Res. 620:1993;339-342.
11. Chapman V., Dickenson A.H. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res. 573:1992;321-323.
12. 2 agonists. Brain Res. 553:1991;65-74.
13. Cox J., Guthrie R., Macrae M., Kehoe E.J. MK-801 impairs acquisition and expression of conditioned responses in the rabbit nictitating membrane preparation. Psychobiology. 22:1994;156-166.
14. Cross A.J., Murray T.K., Snape M.F. Characterization of learning and memory deficits following NMDA receptor antagonism. Amino Acids. 8:1995;79-87.
15. Dai H., Carey R.J. The NMDA receptor antagonist MK-801 can impair attention to exteroceptive stimuli. Behav. Brain Res. 62:1994;149-156.
16. Danysz W., Zajaczkowski W., Parsons C.G. Modulation of learning processes by ionotropic glutamate receptor ligands. Behav. Pharmacol. 6:1995;455-474.
17. Elliott K., Minami N., Kolesnikov Y., Pasternak G., Inturrisi C. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, Ngnitro-l-arginine, attenuate analgesic tolerance to the μ-opioid morphine but not to κ-opioids. Pain. 56:1994;69-75.
18. Emmett-Oglesby M.W., Herz A. Opioid modulation of the discriminative stimulus produced by pentylenetetrazol. Psychopharmacology (Berlin). 92:1987;313-319.
19. Ferkany J.W., Hamilton G.S., Patch R.J., Huang Z., Borosky S.A., Bednar D.L., Jones B.E., Zubrowski R., Willetts J., Karbon E.W. Pharmacological profile of NPC 17742 (2R,4r,5s-(2-amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid), a potent, selective and competitive N-methyl-D-aspartate receptor antagonist. J. Pharmacol. Exp. Ther. 264:1993;256-264.
20. French E.D. Competitive NMDA receptor antagonists attenuate phencyclidine-induced excitations of A10 dopamine neurons. Eur. J. Pharmacol. 217:1992;1-7.
21. Gold L.H., Balster R.L. Effects of NMDA receptor antagonists in squirrel monkeys trained to discriminate the competitive NMDA receptor antagonist NPC 12626 from saline. Eur. J. Pharmacol. 230:1993;285-292.
22. Grech D.M., Willetts J., Balster R.L. Pharmacological specificity of N-methyl-D-aspartate discrimination in rats. Neuropharmacology. 32:1993;349-354.
23. Gutstein H.B., Trujillo K.A. MK-801 inhibits the development of morphine tolerance at spinal sites. Brain Res. 626:1993;332-334.
24. Haberny K.A., Young G.A. Acute interactive effects of MK-801 and morphine on cortical EEG and EEG power spectra in rats. Brain Res. Bull. 36:1995;325-331.
25. Herling S., Coale E.H., Valentino R.J., Hein D.W., Woods J.H. Narcotic discrimination in pigeons. J. Pharmacol. Exp. Ther. 214:1980;139-146.
26. Herman B.H., Vocci F., Bridge P. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Neuropsychopharmacology. 13:1995;269-293.
27. Holtzman S.G. Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkeys. Psychopharmacology (Berlin). 77:1982;295-300.
28. Hunter J.C., Atwal P., Woodruff G.N., Singh L. Differential modulation of kappa and mu opioid antinociception by the glycine/NMDA receptor agonist D-serine. Br. J. Pharmacol. 112:1994;1002-1003.
29. Jeziorski M., White F.J., Wolf M.E. MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse. 16:1994;137-147.
30. Kest B., Marek P., Liebeskind J.C. The specific N-methyl-D-aspartate (Nmda) receptor antagonist MK-801 blocks U-50,488, but not morphine antinociception. Brain Res. 589:1992;139-142.
31. Koek W., Woods J.H. Partial generalization in pigeons trained to discriminate morphine from saline. Applications of receptor theory Drug Dev. Res. 16:1989;169-181.
32. Koek W., Woods J.H., Colpaert F.C. N-methyl-D-aspartate antagonism and phencyclidine-like activity. A drug discrimination analysis J. Pharmacol. Exp. Ther. 253:1990;1017-1025.
33. Koek W., Colpaert F.C., Vignon J. Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline. Pharmacological and behavioral characterization of intermediate levels of drug lever selection J. Pharmacol. Exp. Ther. 264:1993;746-756.
34. Kolesnikov Y.A., Ferkany J., Pasternak G.W. Blockade of μ- and κ1 opioid analgesic tolerance by NPC17742, a novel NMDA antagonist. Life Sci. 53:1993;1489-1494.
35. Lipa S.M., Kavaliers M. Sex differences in the inhibitory effects of the NMDA antagonist, MK-801, on morphine and stress-induced analgesia. Brain Res. Bull. 24:1990;627-630.
36. 1 and N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. USA. 91:1994;8537-8541.
37. Lutfy K., Hurlbut D.E., Weber E. Blockade of morphine-induced analgesia and tolerance in mice by MK-801. Brain Res. 616:1993;83-88.
38. Lutfy K., Woodward R.M., Keana J.F., Weber E. Inhibition of clonic seizure-like excitatory effects induced by intrathecal morphine using two NMDA receptor antagonists. MK-801 and ACEA-1011 Eur. J. Pharmacol. 252:1994;261-266.
39. Mansbach R.S. Effects of NMDA receptor ligands on sensorimotor gating in the rat. Eur. J. Pharmacol. 202:1991;61-66.
40. Mansbach R.S., Balster R.L. Pharmacological specificity of the phencyclidine discriminative stimulus in rats. Pharmacol. Biochem. Behav. 39:1991;971-975.
41. Marek P., Ben-Eliyahu S., Gold M., Liebeskind J.C. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res. 547:1991;77-81.
42. Monaghan D.T., Bridges R.J., Cotman C.W. The excitatory amino acid receptors. Their classes, pharmacology, and distinct properties in the function of the central nervous system Annu. Rev. Pharmacol. Toxicol. 29:1989;365-402.
43. Müller W., Kipfer P., Lowe D.A., Urwyler S. Syntheses of biphenyl analogues of AP7, a new class of competitive N-Methyl-D-aspartate (Nmda) receptor antagonists. Helv. Chim. Acta. 78:1995;2026-2035.
44. Overton D.A. A comparison of the discriminable CNS effects of ketamine, phencyclidine and pentobarbital. Arch. Int. Pharmacodyn. 215:1975;180-189.
45. Patat A., Molinier P., Hergueta T., Brohier S., Zieleniuk I., Danjou Ph., Warot D., Puech A. Lack of amnestic, psychotomimetic or impairing effect on psychomotor performance of eliprodil, a new NMDA antagonist. Int. Clin. Psychopharmacol. 9:1994;155-162.
46. Picker M.J., Doty P., Negus S.S., Mattox S.R., Dykstra L.A. Discriminative stimulus properties of U50,488 and morphine. Effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists J. Pharmacol. Exp. Ther. 254:1990;13-22.
47. Pulvirenti L., Swerdlow N.R., Koob G.F. Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine. Pharmacol. Biochem. Behav. 40:1991;841-845.
48. Pulvirenti L., Maldonado-Lopez R., Koob G.F. NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat. Brain Res. 594:1992;327-334.
49. Rosecrans J.A., Goodloe M.H., Bennett G.J., Hirschhorn I.D. Morphine as a discriminative cue. Effects of amine depletors and naloxone Eur. J. Pharmacol. 21:1973;252-256.
50. Sanger D.L., Joly D. The effects of NMDA receptor antagonists and sigma ligands on the acquisition of conditioned fear in mice. Psychopharmacology (Berlin). 104:1991;27-34.
51. Shannon H.E. Evaluation of phencyclidine analogs on the basis of their discriminative stimulus properties in the rat. J. Pharmacol. Exp. Ther. 216:1981;543-551.
52. Shannon H.E., Holtzman S.G. Blockade of the discriminative effects of morphine in the rat by naltrexone and naloxone. Psychopharmacology (Berlin). 50:1976;119-124.
53. Sharp F.R., Liu J., Nickolenko J., Bontempi B. NMDA and D1 receptors mediate induction of c-fos and junB genes in striatum following morphine administration. Implications for studies of memory Behav. Brain Res. 66:1995;225-230.
54. Singh L., Menzies R., Tricklebank M.D. The discriminative stimulus properties of (+)-HA-966, an antagonist at the glycine/N-methyl-D-aspartate receptor. Eur. J. Pharmacol. 186:1990;129-132.
55. Singh L., Donald A.E., Foster A.C., Hutson P.H., Iversen L.L., Iversen S.D., Kemp J.A., Leeson P.D., Marshall G.R., Oles R.J., Priestley T., Thorn L., Tricklebank M.D., Vass C.A., Williams B.J. Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects. (+)-HA966 is a selective glycine/N-methyl-D-aspartate receptor antagonist but (-)-HA966 is a potent (δ-butyrolactone-like sedative Proc. Natl. Acad. Sci. USA. 87:1990;347-351.
56. Suh H.W., Song D.K., Kim Y.H., Yoo J.S., Tseng L.F. Differential antagonism by MK-801 against antinociception induced by opioid receptor agonists administered supraspinally in mice. Eur. J. Pharmacol. 263:1994;217-221.
57. Tanganelli S., Antonelli T., Morari M., Bianchi C., Beani L. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci. Lett. 122:1991;270-272.
58. Thompson D.M., Mastropaolo J., Winsauer P.J., Moerschbaecher J.M. Repeated acquisition and delayed performance as a baseline to assess drug effects on retention in monkeys. Pharmacol. Biochem. Behav. 25:1986;201-207.
59. Tiseo P.J., Cheng J., Pasternak G.W., Inturrisi C.E. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614. Assessment of opioid receptor changes J. Pharmacol. Exp. Ther. 268:1994;195-201.
60. Trujillo K.A., Akil H. The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality. Pharmacol. Biochem. Behav. 38:1991;673-675.
61. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 251:1991;85-87.
62. Tzschentke T.M., Schmidt W.J. N-Methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci. Lett. 193:1995;37-40.
63. Urwyler S., Lowe D., Meier C., Mhller W. Biphenyl-AP7-derivatives, a new class of competitive N-methyl-D-aspartate receptor antagonists. In vitro pharmacology J. Neurochem. (Suppl.). 65:1995;S12C.
64. Wedzony K., Golembiowska K., Zazula M. Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats. Naunyn Schmiedebergs Arch. Pharmacol. 350:1994;555-562.
65. Willetts J., Balster R.L. The discriminative stimulus effects of N-methyl-D-aspartate antagonists in phencyclidine-trained rats. Neuropharmacology. 27:1988;1249-1256.
66. Willetts J., Balster R.L. Effects of competitive and noncompetitive N-methyl-D-aspartate (Nmda) antagonists in rats trained to discriminate NMDA from saline. J. Pharmacol. Exp. Ther. 251:1989;627-633.
67. Willetts J., Balster R.L. Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists. J. Pharmacol. Exp. Ther. 249:1989;438-443.
68. Willetts J., Bobelis D.J., Balster R.L. Drug discrimination based on the competitive N-methyl-D-aspartate antagonist, NPC 12626. Psychopharmacology (Berlin). 99:1989;458-462.
69. Wong E.H., Kemp J.A., Priestly T., Knight A.R., Woodruff G.N., Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA. 83:1986;7104-7108.
70. Woods J.H., Bertalmio A.J., Young A.M., Essman W.D., Winger G. Receptor mechanisms of opioid drug discrimination. Colpaert F.C., Balster R.L. Transduction mechanisms of drug stimuli. 1988;95-106 Springer Verlag, Berlin.
71. Yamamoto T., Yaksh T.L. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy. Neurosci. Lett. 135:1992;67-70.